Showing 31 - 40 of 106
By introducing n (1) firms with infinite cross-price elasticity (i.e. generic drugs), we explore the effects of competition on the optimal pricing strategies under a Reference Pricing Scheme (RPS). A two-stage model repeated infinite number of times is presented. When stage 1 is competitive, the...
Persistent link: https://www.econbiz.de/10010870801
Persistent link: https://www.econbiz.de/10012314486
Persistent link: https://www.econbiz.de/10010064731
In a pharmaceuticals Reference Price Scheme (RPS), firms are free to set their prices, but the (insured) consumer pays only the difference between the Reference level (R) and the actual price of the drug, if this is higher than R.By introducing n (1) firms with infinite cross-price elasticity...
Persistent link: https://www.econbiz.de/10014201483
In a pharmaceutical Reference Price Scheme (RPS), firms are free to set their prices, but the (insured) consumer pays only the difference between the Reference level (R) and the actual price of the drug, if this is higher than R. By introducing n ( 1) firms with in nite cross-price elasticity...
Persistent link: https://www.econbiz.de/10014041337
We here address the causal relationship between the maternal genetic risk for depression and child human capital using UK birth-cohort data. We find that an increase of one standard deviation (SD) in the maternal polygenic risk score for depression reduces their children's cognitive and...
Persistent link: https://www.econbiz.de/10013471350
Persistent link: https://www.econbiz.de/10014314865
We consider the link between poverty and subjective well-being, and focus in particular on the role of time. We use panel data on 42,500 individuals living in Germany from 1992 to 2010 to uncover four empirical relationships. First, life satisfaction falls with both the incidence and intensity...
Persistent link: https://www.econbiz.de/10010739011
We consider the link between poverty and subjective well-being, and focus in particular on potential adaptation to poverty. We use panel data on almost 45,800 individuals living in Germany from 1992 to 2011 to show first that life satisfaction falls with both the incidence and intensity of...
Persistent link: https://www.econbiz.de/10010739092
In the last decade the pace of innovation in medical technology has accelerated: hence the need to better identify and understand the real forces behind the adoption and diffusion of medical technology innovations in clinical practice. Among these forces, financial incentives may be expected to...
Persistent link: https://www.econbiz.de/10008871734